Zobrazeno 1 - 10
of 37
pro vyhledávání: ''
Publikováno v:
Journal of Cancer Research and Therapeutics. 17:276
Until recently, standard treatment for advanced melanoma comprised basically dacarbazine and interleukin-2, leading to low response rates and significant toxicity. These days, new treatments such as immunotherapy (anti-CTLA4 and anti-PD1 antibodies)
Publikováno v:
Journal of Cancer Research and Therapeutics. 17:530
Aim: The aim was to study the pattern of adverse drug reaction (ADR) provoked by anticancer therapy and to assess the quality of life (QoL) in cancer patients. Materials and Methods: This study was conducted in Tamil Nadu on 75 patients from February
Autor:
Karthikeyan Pethusamy, Sunil Singh, Subhradip Karmakar, Joyeeta Talukdar, Ruby Dhar, Ashikh Seethy, Goura Kishor Rath, Tryambak Srivastava
Publikováno v:
Journal of Cancer Research and Therapeutics. 17:834
Immunotherapy is a treatment that uses specific components of a person's immune system to fight diseases. This is usually done by stimulating or assisting one's immune system is attacking the offending agent - for instance, in the case of cancer - th
Publikováno v:
Journal of Cancer Research and Therapeutics. 17:797
Purpose: The purpose was to evaluate the effect of thermal ablation combined with activated functional killer (AFK) cells immunotherapy for patients with malignant tumors. Materials and Methods: A cohort of 10 patients with malignancies received ther
Publikováno v:
Journal of Cancer Research and Therapeutics. 16:53
Aim of Study: Cardiac complications may be observed after hematopoietic stem cell transplantation (HSCT). Despite significant improvement in supportive care, HSCT may be associated with significant morbidity and mortality. In this study, the aim was
Autor:
Hisao Imai, Masanobu Yamada, Nodoka Watase, Keita Mori, Koichi Minato, Takeshi Hisada, Kyoichi Kaira
Publikováno v:
Journal of Cancer Research and Therapeutics. 16:764
Background The benefits of second-line chemotherapy on the overall survival (OS) of small-cell lung cancer (SCLC) patients might be confounded by subsequent therapies. In this study, we aimed to determine the influence of progression-free survival (P
Autor:
Cem Mirili, Ali Yilmaz
Publikováno v:
Journal of Cancer Research and Therapeutics. 16:189
Coexistence of malignant melanoma and renal cell cancer (RCC) is a rare phenomenon, but this issue becomes increasingly popular. The objective of the current study is to present a case with coexistent anorectal melanoma (ANM) and papillary RCC detect
Publikováno v:
Journal of Cancer Research and Therapeutics. 16:638
Covid19 has become a major public health problem in India and the rest of the world. The dramatic rise in the incidence of COVID 19 cases has severely challenged our healthcare system and forced us to work with limited infrastructure, resources, and
Autor:
Mohammad Hossein Mohammadi, Ahmad Ahmadzadeh, Fatemeh Salarpour, Sara Faraahi, Kourosh Goudarzipour, Atefeh Allahbakhshian, Mehdi Allahbakhshian Farsani
Publikováno v:
Journal of Cancer Research and Therapeutics. 16:23
Objective: Growth factor independence 1 (GFI1), a transcriptional repressor, is required for hematopoietic stem cell maintenance and self-renewal in addition to controlling differentiation and proliferation of myeloid cells. As murine studies have de
Publikováno v:
Journal of Cancer Research and Therapeutics. 16:1203
In recent times, research on the use of ultrahigh-dose rates delivered in super-fast times in cancer treatment has been garnering interest. This has brought about the term "FLASH" radiotherapy (RT). Thus, in the present study, we systematically revie